Artelo Biosciences short interest was 64.32% of the float on March 31st, according to new data we received from Benzinga. Short interest totaled 472,907 shares, which was an increase of 1,164.12% from March 13th.
It is estimated that it would take 1.0 days for short sellers to buy back their shares, with current trading volumes.
Artelo Biosciences Hedge Fund Activity
We have seen 8 institutional investors add shares of Artelo Biosciences stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 33,412 shares (+15986.6%) to their portfolio in Q4 2025, for an estimated $40,762
- TWO SIGMA INVESTMENTS, LP added 20,669 shares (+inf%) to their portfolio in Q4 2025, for an estimated $25,216
- DRW SECURITIES, LLC removed 17,185 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $20,965
- VIRTU FINANCIAL LLC added 16,865 shares (+inf%) to their portfolio in Q4 2025, for an estimated $20,575
- GEODE CAPITAL MANAGEMENT, LLC added 11,398 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,905
- TOWER RESEARCH CAPITAL LLC (TRC) added 1,903 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,321
- MORGAN STANLEY removed 1,100 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,342
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
